Ocera Therapeutics
Latest round
- Series C
Last raised
- Feb 2008
Total raised
- $62M
Investors
- 9
About Ocera Therapeutics
Ocera Therapeutics, Inc.Founded in San Diego, US, Ocera Therapeutics, Inc. specializes in biopharmaceutical development. The company underwent a merger in April 2013 with a subsidiary of Tranzyme, transforming it into a public entity.00 mn, was completed on March 24, 2013.Ocera Therapeutics focuses on developing innovative biopharmaceutical solutions aimed at addressing critical healthcare needs. The company's core product offerings include a range of therapeutics targeting various chronic conditions, particularly in the fields of oncology and autoimmune diseases. These products are designed to enhance patient outcomes through mechanisms that involve modulation of the immune response or targeted cell therapy. Ocera Therapeutics primarily serves healthcare institutions, including hospitals and specialty clinics, catering to a diverse client base that includes healthcare providers, patients, and potentially research institutions involved in clinical trials.Ocera Therapeutics generates revenue through a structured model that includes direct sales to healthcare providers and partnerships with pharmaceutical distributors. In the most recent year, the company's revenue amounted to USD 609,000, with an EBITDA of USD -25,641,000. The company has established a transaction framework supporting both B2B and direct-to-consumer sales, enabling it to reach a wide audience. Revenue is derived from the sale of its flagship therapeutics, with clients typically engaging in bulk purchasing agreements or subscription models for ongoing supply. Specific pricing plans are tailored to the nature of the products and services, reflecting the value and innovation offered by Ocera Therapeutics' proprietary therapies.Ocera Therapeutics has plans to develop new products targeting oncology and autoimmune diseases, with specific launch timelines yet to be announced. The company is also considering expansion into new geographic markets, including additional regions in Europe by the end of 2015.00 mn will be utilized to support these initiatives, enhancing product development and facilitating market entry efforts.
Who invested in Ocera Therapeutics
9 investors across 3 rounds
See all investors in Ocera Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ocera Therapeutics
Who invested in Ocera Therapeutics?
Ocera Therapeutics has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ocera Therapeutics raised?
Ocera Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Ocera Therapeutics last raise money?
Ocera Therapeutics's most recent round on record is a Series C, in Feb 2008.
What does Ocera Therapeutics do?
Ocera Therapeutics is a pharmaceuticals company.
Where is Ocera Therapeutics headquartered?
Ocera Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Ocera Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Ocera Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Ocera Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.